The expression and mutation patterns of p53 were studied in a series of 68
benign pleomorphic adenomas and 237 malignant salivary gland tumors, p53 ov
erexpression (nuclear staining exceeding 10%) was detected in 20% of the ma
lignant salivary gland tumors, with the highest prevalence observed in poly
morphous low grade adenocarcinoma, squamous cell carcinoma, and carcinoma e
x pleomorphic adenoma and the lowest in adenoid cystic carcinoma and acinic
cell carcinoma. In contrast, none of the 68 benign pleomorphic adenomas ha
d nuclear staining exceeding 10%. SSCP and nucleotide sequence analysis of
exons 4 to 9 of p53 in 19 malignant tumors revealed 9 mutations in 7 tumors
. Our findings indicate that p53 may be a useful marker to help discriminat
e between benign and malignant salivary gland tumors.